26.12.2014 Views

Clinical Biochemistry of Domestic Animals (Sixth Edition) - UMK ...

Clinical Biochemistry of Domestic Animals (Sixth Edition) - UMK ...

Clinical Biochemistry of Domestic Animals (Sixth Edition) - UMK ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

796<br />

Chapter | 26 Cerebrospinal Fluid<br />

Oligoclonal bands are associated with disease and are seen<br />

in a high percentage <strong>of</strong> people with multiple sclerosis or<br />

encephalitis. These bands, readily identifiable against the<br />

low background <strong>of</strong> normal polyclonal IgG in the CSF, are<br />

thought to represent the products <strong>of</strong> a limited number <strong>of</strong><br />

plasma cell clones. Oligoclonal bands unique to CSF (i.e.,<br />

not present in serum) indicate intrathecal synthesis <strong>of</strong><br />

immunoglobulin and may be more sensitive than the IgG<br />

index in detecting this synthesis. People with multiple<br />

sclerosis may have a normal IgG index yet have CSF oligoclonal<br />

banding; thus, the demonstration <strong>of</strong> these bands<br />

is considered by some to be the single most useful test in<br />

the diagnosis <strong>of</strong> multiple sclerosis ( Kjeldsberg and Knight,<br />

1993 ). Oligoclonal bands are also seen in patients with<br />

inflammatory diseases and in some patients with neoplasia<br />

( Fishman, 1992 ). Occasionally, a single (monoclonal) band<br />

is identified in the CSF electrophoretic pattern <strong>of</strong> people.<br />

Monoclonal bands have been seen in neurologically normal<br />

people as well as in patients with neurological disease<br />

( Kjeldsberg and Knight, 1993 ).<br />

8 . Other CSF Proteins<br />

Numerous attempts have been made to correlate specific<br />

CSF proteins, particularly “ brain-specific ” proteins, with<br />

specific diseases. Proteins such as C-reactive protein, interferon,<br />

myelin basic protein, and S-100 are increased in<br />

the CSF associated with neurological disease, but these<br />

increases are found in many heterogeneous conditions. This<br />

nonspecificity limits the clinical utility <strong>of</strong> many <strong>of</strong> these specific<br />

protein assays. However, the measurement <strong>of</strong> some <strong>of</strong><br />

these proteins is thought to be useful as a screening procedure<br />

for neurological disease or as an indication <strong>of</strong> prognosis<br />

(Fishman, 1992 ; Kjeldsberg and Knight, 1993 ; Lowenthal<br />

et al. , 1984 ). Immunoassay detection in the CSF <strong>of</strong> the brainderived<br />

protein 14-3-3 appears to be helpful for the diagnosis<br />

<strong>of</strong> transmissible spongiform encephalopathies in both<br />

animals and people ( Hsich et al. , 1996 ; Sanchez-Juan et al. ,<br />

2006 ). An autoantibody against canine glial fibrillary acidic<br />

protein present in astrocytes has been detected in the CSF <strong>of</strong><br />

two pug dogs affected with necrotizing encephalitis ( Uchida<br />

et al. , 1999 ). However, it is unknown if the presence <strong>of</strong> this<br />

antibody is a primary or secondary phenomenon.<br />

9 . Plasma Proteins in the CSF<br />

Alterations in plasma proteins may be reflected in the CSF.<br />

For example, in people, the serum protein monoclonal gammopathy<br />

<strong>of</strong> multiple myeloma may be evident in the CSF.<br />

Bence Jones proteins are also readily seen in the CSF. The<br />

high molecular weight paraproteins do not cross the normal<br />

blood-brain barrier, however. Serum protein electrophoresis<br />

is indicated in patients with elevated CSF globulins to clarify<br />

the source <strong>of</strong> the globulins ( Fishman, 1992 ).<br />

D . Antibody Titers<br />

The CSF antibody titer can be measured for a number <strong>of</strong><br />

diseases (Dubey, 1990b; Greene, 1990 ). Interpretation<br />

<strong>of</strong> the results is confounded by the need to differentiate<br />

among titers caused by vaccination, exposure to the antigen<br />

without development <strong>of</strong> the disease, and actual disease.<br />

Interpretation <strong>of</strong> CSF antibody titers could be aided by an<br />

accurate vaccination history, comparison <strong>of</strong> CSF and serum<br />

titers, assessment <strong>of</strong> blood-brain/CSF barrier function, and<br />

intrathecal immunoglobulin production by determination <strong>of</strong><br />

albumin and immunoglobulin indices, determination <strong>of</strong> CSF<br />

IgM levels, and analysis <strong>of</strong> acute and convalescent samples<br />

(Chrisman, 1992 ; Green et al. , 1993 ; Porter et al. , 2004 ).<br />

E . Glucose<br />

Increased CSF glucose usually reflects hyperglycemia.<br />

Decreased CSF glucose occurs with several disorders <strong>of</strong> the<br />

nervous system, particularly acute, bacterial, fungal, amebic,<br />

or tuberculous meningitis. In people, low CSF glucose is also<br />

characteristic <strong>of</strong> diffuse carcinomatous meningitis, meningeal<br />

cysticercosis or trichinosis, and syphilitic meningitis.<br />

The major factors responsible for low CSF glucose levels are<br />

inhibition <strong>of</strong> the entry <strong>of</strong> glucose because <strong>of</strong> the alteration <strong>of</strong><br />

membrane glucose transport and increased anaerobic glycolysis<br />

by neural tissue. As noted previously, hyperglycemia<br />

elevates the CSF glucose, which may mask a decreased CSF<br />

level. Therefore, calculation <strong>of</strong> a CSF/serum glucose ratio<br />

has been recommended to identify pathologically low CSF<br />

glucose levels ( Deisenhammer et al. , 2006 ; Kjeldsberg and<br />

Knight, 1993 ). A CSF/serum glucose ratio less than 0.4 to 0.5<br />

is considered to be pathological in people ( Deisenhammer<br />

et al. , 2006 ). A low CSF glucose level in the absence <strong>of</strong> hypoglycemia<br />

indicates a diffuse, meningeal disorder, rather than<br />

focal disease ( Fishman, 1992 ; Kjeldsberg and Knight, 1993 ).<br />

Decreased CSF glucose classically has been associated with<br />

bacterial meningitis, but many human patients with bacterial<br />

meningitis have normal CSF glucose levels. Therefore, the<br />

recommendation has been made that CSF glucose need be<br />

measured only if the opening CSF pressure, cell count, cytospin<br />

differential, and protein are inconclusive ( Hayward et al. ,<br />

1987 ). CSF glucose concentration and CSF/serum glucose<br />

ratio are not routinely measured in veterinary medicine, possibly<br />

because <strong>of</strong> the lack <strong>of</strong> specificity and availability <strong>of</strong> more<br />

specific tests in most instances.<br />

F . Enzymes<br />

Numerous enzymes have been assayed in the CSF <strong>of</strong> animals<br />

( Furr and Tyler, 1990 ; Jackson et al. , 1996 ; Rand et al. ,<br />

1994b ; Wilson, 1977 ). Of these, creatine kinase has received<br />

the most attention, and opinions <strong>of</strong> its usefulness are conflicting.<br />

Although Furr and Tyler confirmed previous observations<br />

that CSF creatine kinase activity was elevated in

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!